OPNTOPIANT PHARMACEUTICALS, INC.

Nasdaq opiant.com


$ 20.63 $ -0.12 (-0.58 %)    

Wednesday, 01-Mar-2023 15:59:55 EST
QQQ $ 445.88 $ 2.85 (0.64 %)
DIA $ 395.58 $ 1.12 (0.28 %)
SPY $ 523.16 $ 2.39 (0.46 %)
TLT $ 90.86 $ 0.51 (0.56 %)
GLD $ 218.12 $ 1.83 (0.85 %)
$ 20.65
$ 20.63 x 100
$ 20.68 x 100
-- - --
$ 7.34 - $ 29.25
562,778
na
106.11M
$ 0.61
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-14-2022 09-30-2022 10-Q
2 08-11-2022 06-30-2022 10-Q
3 05-10-2022 03-31-2022 10-Q
4 03-15-2022 12-31-2021 10-K
5 11-12-2021 09-30-2021 10-Q
6 08-05-2021 06-30-2021 10-Q
7 05-11-2021 03-31-2021 10-Q
8 03-04-2021 12-31-2020 10-K
9 11-12-2020 09-30-2020 10-Q
10 08-06-2020 06-30-2020 10-Q
11 05-12-2020 03-31-2020 10-Q
12 03-04-2020 12-31-2019 10-K
13 11-12-2019 09-30-2019 10-Q
14 08-08-2019 06-30-2019 10-Q
15 05-09-2019 03-31-2019 10-Q
16 03-21-2019 12-31-2018 10-K
17 11-07-2018 09-30-2018 10-Q
18 08-09-2018 06-29-2018 10-Q
19 05-08-2018 03-31-2018 10-Q
20 12-04-2017 10-31-2017 10-Q
21 10-13-2017 07-31-2017 10-K
22 06-14-2017 04-30-2017 10-Q
23 03-15-2017 01-31-2017 10-Q
24 12-15-2016 10-31-2016 10-Q
25 10-28-2016 07-31-2016 10-K
26 06-08-2016 04-30-2016 10-Q
27 03-15-2016 01-31-2016 10-Q
28 12-14-2015 10-31-2015 10-Q
29 10-26-2015 07-31-2015 10-K
30 06-12-2015 04-30-2015 10-Q
31 03-17-2015 01-31-2015 10-Q
32 12-09-2014 10-31-2014 10-Q
33 10-27-2014 07-31-2014 10-K
34 06-10-2014 04-30-2014 10-Q
35 03-17-2014 01-31-2014 10-Q
36 12-16-2013 10-31-2013 10-Q
37 10-29-2013 07-31-2013 10-K
38 06-14-2013 04-30-2013 10-Q
39 03-18-2013 01-31-2013 10-Q
40 12-20-2012 10-31-2012 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 indivior-acquires-opiant-pharmaceuticals-strengthening--its-addiction-treatment-and-science-portfolio

Indivior PLC (OTCPK:INVVY) (LSE:INDV) has completed the acquisition of Opiant Pharmaceuticals, Inc. (NASDAQ: OPNT) The transact...

 opiant-pharmaceuticals-announces-cfius-approval-for-proposed-acquisition-by-indivior-plc-under-the-terms-of-the-agreement-indivior-will-acquire-all-the-outstanding-shares-of-opiant-for-upfront-consideration-of-2000-per-share-in-cash-at-closing

CFIUS clearance represents the final required regulatory approval to complete the proposed merger   Completion remains ...

 opiant-pharmaceuticals-announces-expiration-of-hart-scott-rodino-waiting-period-for-proposed-acquisition-by-indivior-plc

Opiant Pharmaceuticals Inc. (NASDAQ:OPNT) announced today the expiration of the waiting period under the United States (U.S.) H...

Core News & Articles

- Reuters

 analyzing-opiant-pharmas-short-interest

Opiant Pharma's (NASDAQ:OPNT) short percent of float has risen 148.0% since its last report. The company recently reported ...

 how-is-the-market-feeling-about-opiant-pharma

Opiant Pharma's (NASDAQ:OPNT) short percent of float has risen 13.79% since its last report. The company recently reported ...

 opiant-pharmaceuticals-announces-completion-of-rolling-nda-submission-for-opnt003-nasal-nalmefene-for-opioid-overdose

Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ:OPNT) today announced it has completed submission of its rolling New Drug Appli...

 why-infinity-pharmaceuticals-shares-tumbled-around-38-here-are-79-biggest-movers-from-yesterday

Gainers Opiant Pharmaceuticals, Inc. (NASDAQ: OPNT) shares surged 113.8% to settle at $20.10 on Monday. Indivior PLC agreed ...

 tesla-amazon-opiant-nu-paramount-lawsuit-earnings-warren-buffetts-increased-stake-draw-investor-attention

Major Wall Street indices closed in the red on Monday, in a reversal of last week’s rally driven by softer inflation data.

 looking-into-opiant-pharmas-recent-short-interest

Opiant Pharma's (NASDAQ:OPNT) short percent of float has fallen 27.5% since its last report. The company recently reported ...

 dow-surges-150-points-crude-oil-falls-sharply

U.S. stocks traded mostly higher toward the end of trading, with the Dow Jones gaining around 150 points on Monday.

 why-opiant-pharmaceuticals-shares-are-trading-higher-by-115-here-are-53-stocks-moving-in-mondays-mid-day-session

Gainers Freight Technologies, Inc. (NASDAQ: FRGT) shares surged 137% to $0.4901 after analysts at Chardan Capital initiated ...

 12-health-care-stocks-moving-in-mondays-intraday-session

Gainers

 silver-rises-over-1-tyson-foods-posts-downbeat-earnings

U.S. stocks traded mixed midway through trading, with the Nasdaq Composite dropping around 60 points on Monday.

 us-stocks-mostly-lower-nasdaq-drops-over-100-points

U.S. stocks traded mostly lower this morning, with the Nasdaq Composite dropping more than 100 points on Monday.

 facebook-stalls-portal--smartwatch-projects-visa-breaks-debit-card-tie-up-with-ftx-3b-bitcoin-withdrawn-from-crypto-exchanges-top-stories-monday-nov-14

Reuters

 12-health-care-stocks-moving-in-mondays-pre-market-session

Gainers Opiant Pharma (NASDAQ:OPNT) stock rose 118.3% to $20.74 during Monday's pre-market session. The market value of ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION